We determined the average numbers of CD3+ and CD11b+ cells in regions containing carcinoma cells and found that T cells were significantly more prevalent than myeloid cells in both well-mod differentiated (p<0.0001) and poorly differentiated tumors (p = 0.03; Figure 1D). The gene discussed is ITGAM; the disease is carcinoma.